BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16273656)

  • 1. Primary pancreatic anaplastic large cell lymphoma, ALK negative: a case report.
    Savopoulos CG; Tsesmeli NE; Kaiafa GD; Zantidis AT; Bobos MT; Hatzitolios AI; Papavramidis ST; Kostopoulos IS
    World J Gastroenterol; 2005 Oct; 11(39):6221-4. PubMed ID: 16273656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK-positive diffuse large B-cell lymphoma: two more cases and a brief literature review.
    Rudzki Z; Rucińska M; Jurczak W; Skotnicki AB; Maramorosz-Kurianowicz M; Mruk A; Piróg K; Utych G; Bodzioch P; Srebro-Stariczyk M; Włodarska I; Stachura J
    Pol J Pathol; 2005; 56(1):37-45. PubMed ID: 15921012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Gastric ALK-negative EBV-negative Anaplastic Large Cell Lymphoma Presenting with Iron Deficiency Anemia.
    Zhang W; Burton S; Wu S; Qian X; Rajeh MN; Schroeder K; Shuldberg M; Merando A; Lai JP
    In Vivo; 2017; 31(4):701-704. PubMed ID: 28652442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).
    Chikatsu N; Kojima H; Suzukawa K; Shinagawa A; Nagasawa T; Ozawa H; Yamashita Y; Mori N
    Mod Pathol; 2003 Aug; 16(8):828-32. PubMed ID: 12920229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
    Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diffuse large B-cell lymphoma with expression of anaplastic lymphoma kinase protein: clinicopathologic and immunohistochemical study of 5 cases].
    Wang WY; Ma ZG; Li GD; Liu WP; Zhong L; Wang Y; Li JM; Li L; Jiang W; Tang Y; Liao DY
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):529-34. PubMed ID: 17134546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD26, together with cell surface adenosine deaminase, is selectively expressed on ALK-positive, but not on ALK-negative, anaplastic large cell lymphoma and Hodgkin's lymphoma.
    Kameoka J; Ichinohasama R; Inoue H; Yamamoto J; Yokoyama H; Tomiya Y; Yamada M; Ishizawa K; Harigae H; Sawai T; Sasaki T
    Leuk Lymphoma; 2006 Oct; 47(10):2181-8. PubMed ID: 17071493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas.
    Thompson MA; Stumph J; Henrickson SE; Rosenwald A; Wang Q; Olson S; Brandt SJ; Roberts J; Zhang X; Shyr Y; Kinney MC
    Hum Pathol; 2005 May; 36(5):494-504. PubMed ID: 15948116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma.
    Han Y; Amin HM; Frantz C; Franko B; Lee J; Lin Q; Lai R
    Leukemia; 2006 Sep; 20(9):1602-9. PubMed ID: 16871283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathologic features of 66 cases of anaplastic lymphoma kinase positive and negative systemic anaplastic large cell lymphoma: a comparative study].
    Shi Y; Chen G; Zhou XG; Gong LP; Yu R; Zheng YY; Xie JL; Jin Y
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):235-9. PubMed ID: 20654121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
    Hsu FY; Johnston PB; Burke KA; Zhao Y
    Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALK-positive neutrophil-rich variant of anaplastic large cell lymphoma diagnosed after head trauma.
    Tamiolakis D; Papadopoulos N; Venizelos J; Kakagia D; Nikolaidou S; Bolioti S; Kouskoukis C
    Onkologie; 2005 Jun; 28(6-7):356-8. PubMed ID: 15933425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic large cell lymphoma--a rare disorder in southern Taiwan.
    Lin CN; Hou CC; Hwang WS; Chuang SS
    Leuk Lymphoma; 2003 Oct; 44(10):1727-31. PubMed ID: 14692525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma.
    Rassidakis GZ; Goy A; Medeiros LJ; Jiang Y; Thomaides A; Remache Y; Cabanillas F; Sarris AH; Gilles F
    Clin Cancer Res; 2003 Jun; 9(6):2213-20. PubMed ID: 12796388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
    Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C
    Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaplastic lymphoma kinase protein positive diffuse large B cell lymphoma; A developing world experience.
    Salat H; Din NU; Moatter T; Kayani N; Ahmed A
    Pathol Res Pract; 2017 Jun; 213(6):649-653. PubMed ID: 28551388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.
    Voena C; Conte C; Ambrogio C; Boeri Erba E; Boccalatte F; Mohammed S; Jensen ON; Palestro G; Inghirami G; Chiarle R
    Cancer Res; 2007 May; 67(9):4278-86. PubMed ID: 17483340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 T-helper responses to the anaplastic lymphoma kinase (ALK) protein in patients with ALK-positive anaplastic large-cell lymphoma.
    Ait-Tahar K; Barnardo MC; Pulford K
    Cancer Res; 2007 Mar; 67(5):1898-901. PubMed ID: 17332315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
    Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J
    Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature.
    Grewal JS; Smith LB; Winegarden JD; Krauss JC; Tworek JA; Schnitzer B
    Ann Hematol; 2007 Jul; 86(7):499-508. PubMed ID: 17396261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.